Education
About Us
Working with TipRanks
Follow Us
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
RESEARCH TOOLSreports
Total Valuation
Salarius Pharmaceuticals has a market cap or net worth of $1.17M. The enterprise value is $439.07K.
Market Cap$1.17M
Enterprise Value$439.07K
Share Statistics
Salarius Pharmaceuticals has 1.75M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.75M
Owned by Insiders2.84%
Owned by Instutions<0.01%
Financial Efficiency
Salarius Pharmaceuticals’s return on equity (ROE) is -3.69 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-368.84%
Return on Assets (ROA)-184.45%
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00%
Revenue Per Employee$0
Profits Per Employee-$2,787,888.5
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Salarius Pharmaceuticals is -0.32. Salarius Pharmaceuticals’s PEG ratio is >-0.01.
PE Ratio-0.32
PS Ratio0.00
PB Ratio1.17
Price to Fair Value1.17
Price to FCF-0.39
Price to Operating Cash Flow-0.39
PEG Ratio>-0.01
Income Statement
In the last 12 months, Salarius Pharmaceuticals had revenue of $0.00 and earned -$5.58M in profits. Earnings per share was -$7.92.
Revenue$0.00
Gross Profit-$2.21K
Operating Income-$4.25M
Pretax Income-$5.58M
Net Income-$5.58M
EBITDA-5.73M
Earnings Per Share (EPS)-7.92
Cash Flow
In the last 12 months, operating cash flow was -$4.53M and capital expenditures $0.00, giving a free cash flow of -$4.53M billion.
Operating Cash Flow-$4.53M
Free Cash Flow-$4.53M
Free Cash Flow per Share-$2.59
Dividends & Yields
Salarius Pharmaceuticals pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-255.60%
Earnings Yield-314.93%
Stock Price Statistics
Beta0.93
52-Week Price Change-82.47%
50-Day Moving Average1.06
200-Day Moving Average1.64
Relative Strength Index (RSI)38.91
Average Volume (3m)404.89K
Important Dates
Salarius Pharmaceuticals upcoming earnings date is May 8, 2025, After Close.
Last Earnings DateMar 24, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Salarius Pharmaceuticals as a current ratio of 2.58, with Debt / Equity ratio of 0.15
Current Ratio2.58
Quick Ratio2.58
Debt to Market Cap0.13
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Salarius Pharmaceuticals has paid $3.00 in taxes.
Income Tax$3.00
Effective Tax Rate0.00%
Enterprise Valuation
Salarius Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.10.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.10
EV to Operating Cash Flow0.10
Balance Sheet
Salarius Pharmaceuticals has $2.43M in cash and marketable securities with $221.87K in debt, giving a net cash position of -$2.21M billion.
Cash & Marketable Securities$2.43M
Total Debt$221.87K
Net Cash-$2.21M
Net Cash Per Share-$1.27
Tangible Book Value Per Share$1.57
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Salarius Pharmaceuticals is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast79.57%